The More Antibiotics You’ve Taken, the Higher Your IBS Risk Appears

If you've gone through more than one round of antibiotics in your life and your gut has felt unpredictable since, a new review is worth your attention. A team led by researchers at Iuliu Hatieganu University of Medicine and Pharmacy in Cluj-Napoca pulled together the largest available evidence on antibiotic use and irritable bowel syndrome (IBS, a chronic condition marked by abdominal pain, bloating, and altered bowel habits without visible tissue damage), and the pattern is consistent: the more antibiotics someone has taken, the higher their odds of developing IBS.

Key takeaways

• People with a history of antibiotic use show roughly double the odds of an IBS diagnosis (odds ratio, or OR, 2.21) compared with people without that history, drawn from a Swedish registry of 29,111 IBS cases and 135,172 controls.
• The risk rises with dose: OR 1.67 after one or two antibiotic courses, climbing to OR 3.36 after three or more courses.
• Not all antibiotic classes carry equal risk, tetracyclines (OR 2.18) and quinolones (OR 2.16) show the strongest ties, while penicillins (OR 1.72) show the smallest, though still real, increase.
• This is observational data, not a randomized trial, so the infection that prompted the antibiotic, not just the drug itself, may be part of the story.

Antibiotic Use Tied to More Than Double the Odds of IBS

The core finding is straightforward: across multiple large population studies synthesized in this narrative review, people who had taken antibiotics were significantly more likely to later be diagnosed with IBS than people who hadn't. The clearest single data point comes from a nationwide Swedish case-control study comparing 29,111 IBS cases against 135,172 matched controls, which found an odds ratio of 2.21 (95% confidence interval 2.14-2.28) for antibiotic-exposed individuals. A separate Danish cohort found a similar signal, with a relative risk of 1.9 for newly diagnosed IBS following antibiotic exposure.

Why This Matters for the Roughly 1 in 10 People Living With IBS

IBS is common, chronic, and has no cure, only symptom management through diet, stress reduction, and sometimes medication, so identifying a modifiable risk factor matters. If antibiotic exposure genuinely contributes to IBS risk, that reframes something most people think of as a routine, low-stakes prescription. Anyone who has taken repeated courses for recurring infections, whether urinary tract infections, sinusitis, or skin infections, falls into the population this review is describing. The takeaway isn't that antibiotics are dangerous, but that their gut-level tradeoffs deserve the same weight as their infection-fighting benefits.

How the Evidence Was Built: Registries, a Cohort, and a 31-Study Meta-Analysis

This isn't a single new experiment; it's a synthesis of existing observational evidence. Beyond the Swedish and Danish data, the review cites a meta-analysis pooling 31 studies and 422,350 patients, which found antibiotic-exposed individuals had an incidence rate ratio (IRR, a measure of how much more often an event occurs in one group versus another) of 1.30 for IBS. The dose-response pattern is the most persuasive piece: people with one or two documented antibiotic courses had an OR of 1.67, while those with three or more courses had an OR of 3.36 (95% CI 3.24-3.49), a gradient that's harder to explain away as coincidence than a single flat association would be.

What This Means If You've Taken Antibiotics Recently

This isn't a reason to refuse antibiotics for a confirmed bacterial infection, untreated infections carry their own serious risks, and a modestly elevated long-term IBS risk doesn't outweigh that in most cases. What it does support is asking more questions before a prescription: is this infection confirmed bacterial (as opposed to viral, where antibiotics do nothing), is a narrower-spectrum option available, and does the standard course length actually need to be that long. If you've had several antibiotic courses over the years and now deal with unexplained bloating, cramping, or irregular bowel habits, it's a reasonable thing to raise with a doctor, though this review can't tell you whether antibiotics specifically caused your symptoms.

The Big Caveat: This Can't Prove Antibiotics Alone Cause IBS

The authors are upfront about a major limitation: confounding by indication. The infection that required antibiotics in the first place, not the drug itself, could be driving some of the elevated IBS risk, particularly since post-infectious IBS is already a recognized phenomenon. All of the underlying data is observational and registry-based, not randomized controlled trials, and this paper itself is a synthesis review rather than new primary research. A related Swedish registry analysis of antibiotics and inflammatory bowel disease found a comparable pattern for a different gut condition, using similar national-registry methodology, underscoring that this confounding challenge isn't unique to this one study.

What Comes Next: A Push for Microbiome-Sparing Prescribing

The review's authors call for stronger antimicrobial stewardship, meaning more selective prescribing, narrower-spectrum drugs when possible, and avoiding antibiotics for infections that don't need them. That call lines up with existing public health data: the CDC's 2025 antibiotic stewardship report found that roughly 75% of acute sinusitis visits still result in an antibiotic prescription despite most patients recovering without one, and dentists alone account for more than 10% of outpatient antibiotic prescriptions. The authors frame "microbiome-sparing" prescribing, not blanket avoidance, as the practical path forward.

Common Questions

Does this mean I should refuse antibiotics when I'm sick? No. This review doesn't argue against antibiotics for confirmed bacterial infections; it argues against unnecessary courses. Untreated bacterial infections carry their own well-established risks that outweigh a modest long-term IBS association.

Which antibiotics carry the highest IBS risk in this review? Tetracyclines (OR 2.18) and quinolones (OR 2.16) showed the strongest associations, followed by macrolides (OR 2.06), with penicillins showing the smallest increase (OR 1.72) among the classes studied.

Is this the same as antibiotic-associated diarrhea? No. Antibiotic-associated diarrhea is a short-term side effect that typically resolves after stopping the drug. The IBS risk described here refers to a chronic diagnosis identified in patients years after antibiotic exposure, tracked through national health registries.

References

1. Abdulrahman Ismaiel, Mhd Bashir Almonajjed, Ahmed Abdelghafar, et al. (2026). The Cost of the Cure: Antibiotic Exposure as a Risk Factor for Irritable Bowel Syndrome. Antibiotics. https://doi.org/10.3390/antibiotics15080772